Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Beth Faiman, PhD, APRN-BC, AOCN

Editor in Chief
Authored Items
From the Editor - TON October 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - October 2019, Vol 12, No 5 in From the Editors
From the Editor - TON August 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - August 2019, Vol 12, No 4 in From the Editors
From the Editor - TON June 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - June 2019, Vol 12, No 3 in From the Editors
From the Editor - TON April 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - April 2019, Vol 12, No 2 in From the Editors
From the Editor - TON February 2019
Beth Faiman, PhD, APRN-BC, AOCN
TON - February 2019, Vol 12, No 1 in From the Editors
From the Editor - TON November 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2018, Vol 11, No 5 in From the Editors
From the Editor - TON July 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2018, Vol 11, No 3 in From the Editors
From The Editor - TON March 2018
Beth Faiman, PhD, APRN-BC, AOCN
TON - March 2018, Vol 11, No 1 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2017, Vol 10, No 6 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2017, Vol 10, No 5 in Cancer Center Profile
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2017, Vol 10, No 4 in From the Editors
Staying Abreast of New Treatments
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Managing Patients with Multiple Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Perceptions of Daratumumab Therapy
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Starting a Patient on Daratumumab
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
What Do Patients Ask About Daratumumab?
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Unmet Needs in Patients with Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
The Challenge of Managing Treatment-Related Toxicites
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Self-Managing Side Effects
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Concerns Over New Multiple Myeloma Therapies
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
How Janssen CarePath Helps Patients
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Survivorship Care and Multiple Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
From The Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - March 2017, Vol 10, No 2 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - January 2017, Vol 10, No 1 in From the Editors
From the Editor - September 2016
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2016, Vol 9, No 5 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON July 2016 Vol 9 No 4 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON May 2016 Vol 9 No 3 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON March 2016 Vol 9 No 2 in From the Editors
From The Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON January 2016 Vol 9 No 1 in From the Editors
Improving the Management of Patients on Oral Regimens
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Conference Correspondent, ASH
Utilizing Patient Support Services
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Conference Correspondent, ASH
The Impact of New Multiple Myeloma Treatments
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent  in Conference Correspondent, ASH
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON November 2015 Vol 8 No 6 in From the Editors
Meeting Update: The International Myeloma Workshop and the Myeloma Nursing Symposium
Beth Faiman, PhD, APRN-BC, AOCN
TON November 2015 Vol 8 No 6 in Conference Correspondent
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON September 2015 Vol 8 No 5 in From the Editors
Beth Faiman, PhD, APRN-BC, AOCN, Nominated for LLS Woman of the Year
Beth Faiman, PhD, APRN-BC, AOCN
Audiocasts in Original Research
Impact of the Affordable Care Act on Cancer Care: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Conquering the Cancer Care Continuum - Series Three: Fourth Issue in Supplements
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON May 2015 Vol 8 No 3 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON March 2015 Vol 8 No 2 in From the Editors
Side Effect Management: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Conquering the Cancer Care Continuum - Series Three: Third Issue in Supplements
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - January 2015 Vol 8 No 1 in From the Editors
From The Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - November/December 2014 Vol 7 No 6 in From the Editors
Access to Quality Care: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Conquering the Cancer Care Continuum - Series Three: Second Issue in Supplements
Good Manufacturing Practice: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Conquering the Cancer Care Continuum - Series Three: First Issue in Supplements
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September/October 2014 Vol 7 No 5 in From the Editors
The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones
Beth Faiman, PhD, APRN-BC, AOCN
TON - September/October 2014 Vol 7 No 5 in Hematologic Cancers
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - July/August 2014 Vol 7 No 4 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - March/April 2014 Vol 7 No 2 in From the Editors
From The Editor January/February 2014
Beth Faiman, PhD, APRN-BC, AOCN
TON - January/February 2014 Vol 7 No 1 in From the Editors
From the Editor December 2013
Beth Faiman, PhD, APRN-BC, AOCN
TON - December 2013 Vol 6 No 11 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2013 Vol 6 No 10 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - October 2013 Vol 6 No 9 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2013 Vol 6 No 8 in From the Editors
The Role of Biosimilars in Oncology: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Sixth Issue 2013 series: Conquering the Cancer Care Continuum
The Importance of Cancer Survivorship Care Plans: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Fifth Issue 2013 series: Conquering the Cancer Care Continuum in Supplements
From the Editor August 2013
Beth Faiman, PhD, APRN-BC, AOCN
TON - August 2013 Vol 6 No 7 in From the Editors
From the Editor July 2013
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2013 Vol 6 No 6 in From the Editors
Letter from the Editor June 2013
Beth Faiman, PhD, APRN-BC, AOCN
TON - June 2013, Vol 6, No 5 in From the Editors
Personalized Treatment Planning: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Fourth Issue 2013 series: Conquering the Cancer Care Continuum
From The Editor - May 2013
Beth Faiman, PhD, APRN-BC, AOCN
TON - May 2013, Vol 6, No 4 in From the Editors
Hospice Care Options: A Nurse’s Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Third Issue 2013 series: Conquering the Cancer Care Continuum
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - April 2013, Vol 6, No 3 in From the Editors
From The Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - March 2013, Vol 6, No 2 in From the Editors
Classifying and Managing Pain in the Oncology Patient
Beth Faiman, PhD, APRN-BC, AOCN
Second Issue 2013 series: Conquering the Cancer Care Continuum
From the Editor February 2013 Vol 6, No 1
Beth Faiman, PhD, APRN-BC, AOCN
TON - February 2013, Vol 6, No 1 in From the Editors
Carfilzomib-Based Therapies for Multiple Myeloma: A Nurse's Perspective
Beth Faiman, PhD, APRN-BC, AOCN
Web Exclusives
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - December 2012, Vol 5, No 11 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - JUNE 2012 VOL 5, NO 5
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - April 2012, Vol 5, No 3
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Online First
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Online First
Next-Generation Proteasome Inhibition in Multiple Myeloma
Kim Redic, PharmD, BCPS, Beth Faiman, PhD, APRN-BC, AOCN
TON - Supplements
Carfilzomib: A New Agent in the Treatment Armamentarium for Multiple Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Online First
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Online First
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Online First
A Reflection of Gratitude
Beth Faiman, PhD, APRN-BC, AOCN
TON - Daily
We Are All in This Together
Beth Faiman, PhD, APRN-BC, AOCN
TON - March/April 2011, VOL 4, NO 2
Last modified: August 8, 2019